Open access
Aug 2026
KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer.
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) carries high mortality despite neoadjuvant chemotherapy (NAC) and surgical resection, creating an urgent need for prognostic biomarkers to guide treatment. We aimed to determine whether circulating tumor DNA (ctDNA) detected by next-generation sequencing (NGS) predicts...
Krishay Sridalla, Dominic J. Vitello, Madison Cox et al.
· Annals of Surgical Oncology · 0 citations